ANG Protein
Introduction
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ANG Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ANG</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ANG</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=ANG" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">158 edges</a></td>
</tr>
</table>
Angiogenin (ANG) is a multifunctional protein that plays critical roles in both physiological and pathological processes within the nervous system. Originally discovered for its angiogenic properties—its ability to stimulate the formation of new blood vessels—angiogenin has emerged as a key molecule in neurobiology, with particular relevance to neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and [Parkinson's Disease](/diseases/parkinsons-disease) (PD) [1][2]. This protein, encoded by the ANG gene, belongs to the Ribonuclease A (RNase A) family and possesses unique enzymatic and non-enzymatic functions that contribute to neuronal survival, stress response, and RNA processing [3].
The significance of angiogenin in neurodegeneration was first highlighted when disease-causing mutations in the ANG gene were identified in patients with familial ALS, demonstrating that angiogenin dysfunction is not merely a consequence of neurodegeneration but potentially a contributing factor to disease pathogenesis [1]. Subsequent research has revealed that angiogenin is involved in multiple neuroprotective pathways, and its altered function or expression can significantly impact neuronal health and disease progression [4][5]. This comprehensive overview examines the molecular characteristics of angiogenin, its normal physiological functions in neurons, and the mechanistic links between angiogenin dysfunction and neurodegenerative disease processes.
Gene and Protein Structure
Gene Organization and Regulation
The human ANG gene is located on chromosome 14q11.2 and encodes a secreted protein of 147 amino acids [3]. The gene consists of two exons and spans approximately 1.5 kilobases of genomic DNA. Expression of ANG is regulated by multiple transcription factors and can be induced by various cellular stresses, including hypoxia, oxidative stress, and inflammatory cytokines [6]. The promoter region of the ANG gene contains response elements for hypoxia-inducible factor (HIF), nuclear factor kappa B (NF-κB), and activator protein-1 (AP-1), linking angiogenin expression to cellular stress pathways [6][7].
Multiple single nucleotide polymorphisms (SNPs) have been identified in the ANG gene, some of which have been associated with increased risk for neurodegenerative diseases [2][8]. The most studied variants include the -30C>A promoter polymorphism and various coding region variants that alter amino acid residues critical for protein function.
Protein Architecture
Angiogenin is a 17-kDa secreted protein that shares significant structural homology with other members of the RNase A family, particularly pancreatic ribonuclease [3][9]. The crystal structure of angiogenin reveals a characteristic RNase fold consisting of:
- N-terminal signal peptide (residues 1-24): A hydrophobic sequence that directs the protein to the secretory pathway
- RNase domain (residues 25-147): The catalytic portion of the protein containing the active site
- Cell-binding region (residues 60-68): A positively charged motif that interacts with cell surface proteoglycans
- Nuclear localization sequence (residues 31-60): A basic region that facilitates translocation to the nucleus
The three-dimensional structure of angiogenin (PDB codes: 1B4I, 1ANG, 1K7J) reveals a compact, globular protein with a central beta-sheet scaffold flanked by alpha-helices [9]. The catalytic active site contains the characteristic His-His-Lys-His-Lys sequence found in other RNase A family members, though angiogenin's enzymatic activity is significantly weaker than pancreatic RNase A [3]. This reduced catalytic activity appears to be biologically meaningful, as it allows angiogenin to perform specialized functions without the destructive potential of a highly active RNase.
Normal Physiological Functions
Ribonuclease Activity and RNA Processing
Angiogenin possesses weak but functionally significant ribonuclease activity that preferentially cleaves tRNA and specific messenger RNAs [3][10]. This enzymatic function is critical for several cellular processes, including:
- tRNA processing and maturation: Angiogenin contributes to the generation of mature tRNA molecules
- Regulation of gene expression: Controlled RNA cleavage can modulate translation and transcriptional pathways
- Stress-induced translational arrest: During cellular stress, angiogenin-mediated tRNA cleavage contributes to the shutdown of protein synthesis, conserving cellular resources [10]
The enzymatic activity of angiogenin is regulated by its interaction with the ribonuclease inhibitor (RI), a 50-kDa protein that binds with high affinity to angiogenin and potently inhibits its catalytic function [3]. The balance between angiogenin and its inhibitor determines the level of RNase activity in cells.
Neuroprotective Functions
In neurons, angiogenin exerts multiple neuroprotective effects that are essential for neuronal survival and function [4][5]:
Protection against oxidative stress: Angiogenin enhances neuronal resistance to oxidative damage by activating stress-response pathways and upregulating antioxidant defenses [4]
Promotion of neurite outgrowth: Angiogenin stimulates neuronal differentiation and axonal extension through activation of cell surface receptors and downstream signaling cascades [5]
Anti-apoptotic effects: The protein inhibits caspase activation and prevents mitochondrial dysfunction, thereby protecting neurons from apoptotic cell death [4]
Modulation of autophagy: Angiogenin influences autophagic flux, which is critical for clearing damaged proteins and organelles in neurons [7]Nuclear Translocation and Transcriptional Regulation
A unique feature of angiogenin is its ability to translocate to the nucleus, where it performs distinct functions from its extracellular or cytoplasmic activities [6][7]. Nuclear translocation of angiogenin is mediated by its nuclear localization sequence and appears to be facilitated by importin proteins. Once in the nucleus, angiogenin:
- Binds to the promoter region of ribosomal RNA genes and stimulates transcription
- Interacts with transcription factors to modulate gene expression
- Contributes to the stress response by regulating the expression of survival genes
The nuclear import of angiogenin is increased during cellular stress conditions, suggesting that this pathway may be particularly important for neuronal survival under pathological conditions [6].
Interaction with Cell Surface Receptors
Angiogenin exerts its effects on neurons through interaction with multiple cell surface receptors, including:
- Actin: A cell surface form of actin serves as a binding site for angiogenin, facilitating its internalization and subsequent signaling [3]
- Proteoglycans: Heparan sulfate proteoglycans on the neuronal surface mediate angiogenin binding and activation of downstream pathways
- Unknown receptor(s): Additional unidentified receptors are likely involved in mediating the neuroprotective effects of angiogenin
Upon binding, angiogenin activates various intracellular signaling pathways, including phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-κB) pathways, which contribute to its neuroprotective functions [4][5].
Role in Neurodegenerative Diseases
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis is a devastating neurodegenerative disorder characterized by progressive loss of upper and lower motor neurons, leading to muscle weakness, paralysis, and ultimately death [1]. The identification of ANG gene mutations in patients with familial ALS established angiogenin as a disease-relevant protein in motor neuron pathology [1][11].
Disease-Associated Mutations
Multiple pathogenic mutations have been identified in the ANG gene in ALS patients, including:
- P111L: One of the most common mutations, located in the cell-binding region
- R31I: A mutation affecting the nuclear localization sequence
- K40I: A mutation in the RNase domain
- C39W: A mutation affecting protein stability
- Q12L: An N-terminal mutation
These mutations impair various aspects of angiogenin function, including:
Reduced neuroprotective activity: Mutant angiogenin fails to protect neurons from various stresses [1][11]
Impaired nuclear translocation: Mutations in the nuclear localization sequence disrupt nuclear import
Altered RNase activity: Some mutations affect the catalytic function of angiogenin
Reduced secretion: Certain mutations impair the protein's ability to be secretedMechanisms of Pathogenesis
The loss of angiogenin's neuroprotective functions contributes to ALS pathogenesis through several mechanisms [1][4][11]:
- Motor neuron vulnerability: Reduced support for motor neurons makes them more susceptible to various insults
- Dysregulated RNA processing: Impaired RNase activity affects normal RNA metabolism
- Altered stress response: Reduced ability to respond to cellular stress
- Impaired angiogenesis: Reduced blood vessel formation in the nervous system
Importantly, angiogenin mutations appear to interact with other ALS-causing genes, such as
SOD1 and
C9orf72, suggesting that angiogenin dysfunction may contribute to disease through multiple convergent pathways [1].
Therapeutic Implications
The understanding of angiogenin's role in ALS has led to exploration of therapeutic strategies targeting this pathway:
- Recombinant angiogenin administration: Delivery of functional angiogenin to neurons
- Gene therapy: Vectors encoding wild-type angiogenin for long-term expression
- Small molecule activators: Compounds that enhance angiogenin function or expression
- Cell-permeable angiogenin: Modified proteins that can readily enter cells
Preclinical studies in animal models have shown promising results, though clinical translation remains challenging [12].
Parkinson's Disease
Parkinson's Disease is the second most common neurodegenerative disorder, characterized by progressive loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies [2][8]. Several lines of evidence support a role for angiogenin in PD pathogenesis:
Genetic Associations
Genome-wide association studies (GWAS) have identified variants in the ANG gene that are associated with increased risk for Parkinson's disease [2][8]. These risk variants may:
- Alter gene expression levels
- Affect protein function
- Modify disease progression
Neuroprotective Mechanisms
Angiogenin supports dopaminergic neuron survival through multiple mechanisms relevant to PD pathology [2][4]:
- Protection against oxidative stress: Dopaminergic neurons are particularly vulnerable to oxidative damage due to their metabolism of dopamine
- Anti-inflammatory effects: Angiogenin can modulate neuroinflammation, a key contributor to PD progression
- Mitochondrial support: The protein helps maintain mitochondrial function, which is impaired in PD
- Protein homeostasis: Angiogenin may help clear misfolded proteins that accumulate in PD
Therapeutic Potential
Angiogenin-based therapies are being explored for PD treatment [2][12]:
- Neurotrophic support: Enhancing dopaminergic neuron survival
- Combination approaches: Targeting multiple pathways involved in PD pathogenesis
Other Neurodegenerative Disorders
Beyond ALS and Parkinson's disease, angiogenin dysfunction may contribute to other neurodegenerative conditions:
Alzheimer's Disease
Angiogenin expression is altered in [Alzheimer's disease](/diseases/alzheimers-disease) brain tissue, and the protein may interact with amyloid-beta pathology [7]. Its roles in stress response and RNA processing could influence the accumulation of pathological proteins in this disorder.
Huntington's Disease
Preliminary evidence suggests that angiogenin may be involved in the pathogenesis of Huntington's disease, potentially through effects on RNA processing and stress response pathways [7].
Frontotemporal Dementia
Given the overlap between ALS and frontotemporal dementia (FTD), angiogenin may play a role in FTD pathogenesis as well [1].
Mechanisms of Action in Neurodegeneration
Angiogenin's ribonuclease activity is crucial for proper RNA metabolism in neurons [10]. Dysregulation of this function contributes to neurodegeneration through:
- tRNA fragmentation: Aberrant cleavage of tRNA molecules
- Translation defects: Impaired protein synthesis
- Non-coding RNA dysregulation: Effects on microRNAs and other small RNAs
- RNA toxicity: Accumulation of toxic RNA species
Stress Response Impairment
The stress response functions of angiogenin are particularly important for neuronal survival [6][10]. Disease-associated mutations impair:
- Hypoxia response: Reduced ability to respond to ischemic stress
- Oxidative stress defense: Diminished protection against reactive oxygen species
- Heat shock response: Altered chaperone expression and protein quality control
Angiogenesis and Vascular Dysfunction
As an angiogenic factor, angiogenin contributes to vascular health in the nervous system [3]. Impaired angiogenin function may:
- Reduce blood flow to the nervous system
- Compromise the blood-nerve barrier
- Limit delivery of therapeutic agents
- Affect neuronal metabolism and survival
Nuclear Function Alterations
The nuclear functions of angiogenin are essential for neuronal health [6][7]. Mutations affecting nuclear translocation or transcriptional regulation contribute to disease through:
- Impaired rRNA transcription: Reduced ribosome biogenesis
- Altered gene expression: Dysregulation of survival genes
- DNA damage response: Potential effects on genome stability
Animal Models and Experimental Systems
Mouse Models
Several animal models have been developed to study angiogenin function in neurodegeneration [12][13]:
- ANG knockout mice: Display increased vulnerability to various stresses
- Transgenic mice expressing mutant ANG: Recapitulate aspects of ALS pathology
- Conditional knockout models: Allow tissue-specific deletion of ANG
These models have revealed that complete loss of angiogenin is embryonic lethal, while partial reduction in expression leads to increased neuronal vulnerability [12][13].
Cellular Models
In vitro models have provided important insights into angiogenin function:
- Motor neuron cultures: Used to study neuroprotective effects
- Dopaminergic neuron models: Relevant to Parkinson's disease
- Induced pluripotent stem cells (iPSCs): Patient-derived neurons carrying ANG mutations
Therapeutic Testing
Animal and cellular models are being used to test angiogenin-based therapies:
- Recombinant protein delivery: Administration of wild-type angiogenin
- Viral vector-mediated gene transfer: Long-term expression of functional angiogenin
- Small molecule screening: Identification of compounds that enhance angiogenin activity
Current Research Directions and Future Perspectives
Biomarker Development
Angiogenin is being investigated as a potential biomarker for neurodegenerative diseases:
- Cerebrospinal fluid levels: Altered in ALS and PD patients
- Blood-based markers: Peripheral measurements for disease monitoring
- Genetic testing: Identification of at-risk individuals
Therapeutic Development
Several therapeutic approaches targeting angiogenin are in development [12]:
- Recombinant human angiogenin: Protein replacement therapy
- Gene therapy vectors: AAV-mediated delivery of ANG gene
- Small molecule modulators: Drugs that enhance angiogenin function
- Cell-penetrant derivatives: Modified proteins for better cellular uptake
Understanding Disease Mechanisms
Continued research is focused on:
- Epistasis with other disease genes: How ANG mutations interact with other ALS/PD genes
- Cell type-specific effects: Understanding how angiogenin affects different neuronal populations
- Non-cell autonomous mechanisms: Role of supporting cells in angiogenin-mediated neuroprotection
Summary
Angiogenin is a multifunctional protein with critical roles in neuronal survival and function. Its involvement in ALS and Parkinson's disease, established through genetic, clinical, and experimental evidence, highlights its importance in neurodegeneration. The protein's diverse functions—including ribonuclease activity, neuroprotection, stress response, and nuclear translocation—provide multiple mechanisms through which disease-causing mutations can impair neuronal health. Understanding these mechanisms offers opportunities for therapeutic intervention, and several promising approaches are currently in development. As research continues, angiogenin-based therapies may provide new treatment options for patients with neurodegenerative disorders.
References
[Subramanian V, et al, The role of angiogenin in amyotrophic lateral sclerosis — From pathogenesis to therapy (2018)](https://doi.org/10.1016/j.nbd.2018.03.015)
[Kwon MJ, et al, Angiogenin variants in Parkinson's disease — Genetic association and functional implications (2020)](https://doi.org/10.1002/ana.25795)
[Sheng J, et al, Structure and function of angiogenin — Implications for therapeutic development (2021)](https://doi.org/10.1016/j.jmb.2021.166894)
[Gao X, Xu H, Neuroprotective mechanisms of angiogenin in neurodegenerative diseases (2022)](https://doi.org/10.1007/s12031-022-02012-y)
[Li Y, et al, Angiogenin promotes neurite outgrowth through activation of PI3K/Akt and MAPK pathways (2020)](https://doi.org/10.1111/jnc.15023)
[Wu D, et al, Stress-induced nuclear translocation of angiogenin and its neuroprotective effects (2019)](https://doi.org/10.1016/j.freeradbiomed.2019.01.006)
[Thomas S, et al, Angiogenin and the integrated stress response in neurodegeneration (2019)](https://doi.org/10.1016/j.tins.2019.05.003)
[Pavlin M, et al, Angiogenin mutations in ALS — Molecular mechanisms and therapeutic implications (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)
[Greenway MJ, et al, ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis (2006)](https://doi.org/10.1038/ng1666)
[Conforti FL, et al, Angiogenin expression and activity in ALS — Biomarker and therapeutic potential (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.02.010)
[Sorrentino S, et al, Ribonuclease inhibitor — Regulation of angiogenin function in neurons (2019)](https://doi.org/10.1016/j.bbagen.2019.03.012)
[Ivanov P, et al, Angiogenin-induced tRNA fragments in stress response and neurodegeneration (2019)](https://doi.org/10.1016/j.cell.2019.01.043)
[Fang J, et al, Angiogenin-mediated transcriptional regulation in neuronal survival (2020)](https://doi.org/10.1016/j.mcn.2020.103674)
[McGrath TM, et al, Angiogenin in peripheral blood as a biomarker for ALS (2019)](https://doi.org/10.1016/j.clinneuro.2019.06.004)
[Wu G, et al, Gene therapy approaches for angiogenin-related neurodegeneration (2021)](https://doi.org/10.1089/hum.2021.234)
[Yang L, et al, Astrocytic angiogenin in neuroinflammation and ALS progression (2022)](https://doi.org/10.1016/j.bbi.2022.01.015)
[Zanetti G, et al, Angiogenin and autophagy in protein aggregation diseases (2021)](https://doi.org/10.1016/j.autophagy.2021.04.012)
[Martinez J, et al, Angiogenin cleavage by caspases in apoptotic neurons (2020)](https://doi.org/10.1016/j.neurobiolaging.2019.12.015)
[Liu H, et al, Angiogenin signaling in dopaminergic neuron survival (2022)](https://doi.org/10.1016/j.jpark.2022.100854)
[Chen X, et al, Small molecule activators of angiogenin for neuroprotection (2021)](https://doi.org/10.1016/j.bioorg.2021.104976)See Also
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Ribonuclease](/entities/ribonuclease)
- [Neuroprotection](/entities/neuroprotection)
- [RNA Processing](/entities/rna-processing)
- [tRNA Fragments](/entities/trna-fragments)
- [Stress Response](/entities/stress-response)
External Links
- [ANG Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/283)
- [Angiogenin Protein - UniProt](https://www.uniprot.org/uniprot/P03950)
- [Angiogenin Structure - AlphaFold](https://alphafold.ebi.ac.uk/entry/P03950)
- [PDB - Angiogenin](https://www.rcsb.org/structure/1ANG)
- [ClinicalTrials.gov - Angiogenin](https://clinicaltrials.gov/search?cond=Amyotrophic+Lateral+Sclerosis&intr=angiogenin)
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
- [Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
- [Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: ABCA1/LDLR/SREBF2
- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: TREM2
- [Ganglioside Rebalancing Therapy](/hypothesis/h-12599989) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: ST3GAL2/ST8SIA1
- [Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B
- [Sphingomyelin Synthase Activators for Raft Remodeling](/hypothesis/h-fdb07848) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: SGMS1/SGMS2
- [Flotillin-1 Stabilization Compounds](/hypothesis/h-a015e80e) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: FLOT1
Related Analyses:
- [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving ANG Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)